— Know what they know.
Not Investment Advice

BIOQ OTC

Bioqual, Inc.
1W: +0.0% 1M: +0.0% 3M: +1.5% YTD: -14.3% 1Y: -17.5% 3Y: -44.1% 5Y: -59.2%
$33.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 55 · $29.5M mcap · 890748 float · 0.064% daily turnover · Short 74% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BIOQ receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-09-24 C+ C
2026-06-30 None ADDED
2026-06-16 EXISTED None
2026-06-11 None ADDED
2026-05-26 EXISTED None
2026-05-18 None ADDED
2026-05-12 EXISTED None
2026-05-07 None ADDED
2026-05-03 EXISTED None
2026-04-28 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 29 Grade D
Profitability
0
Balance Sheet
93
Earnings Quality
43
Growth
19
Value
49
Momentum
25
Safety
80
Cash Flow
32
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BIOQ scores highest in Balance Sheet (93/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.13
Safe Zone
Piotroski F-Score
3/9
✗ ✓ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-3.54
Unlikely Manipulator
Ohlson O-Score
-6.62
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB+
Score: 61.9/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -2.81x
Accruals: -7.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BIOQ scores 3.13, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BIOQ scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BIOQ's score of -3.54 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BIOQ's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BIOQ receives an estimated rating of BBB+ (score: 61.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-7.08x
PEG
-0.01x
P/S
0.74x
P/B
0.91x
P/FCF
14.87x
P/OCF
13.67x
EV/EBITDA
21.91x
EV/Revenue
0.80x
EV/EBIT
-24.67x
EV/FCF
14.39x
Earnings Yield
-2.60%
FCF Yield
6.72%
Shareholder Yield
1.11%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. BIOQ currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.815
NI / EBT
×
Interest Burden
0.815
EBT / EBIT
×
EBIT Margin
-0.032
EBIT / Rev
×
Asset Turnover
0.860
Rev / Assets
×
Equity Multiplier
1.541
Assets / Equity
=
ROE
-2.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BIOQ's ROE of -2.8% is driven by Asset Turnover (0.860), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$33.00
Median 1Y
$31.18
5th Pctile
$17.46
95th Pctile
$55.66
Ann. Volatility
35.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
ROE 16.7% 18.5% 18.9% 20.5% 18.3% 17.2% 16.4% 14.8% 14.2% 14.6% 9.2% 2.2% 0.9% -1.2% 2.5% 1.3% -2.9% -7.5% -5.7% -2.8% -2.84%
ROA 9.7% 10.6% 11.2% 12.3% 11.4% 10.0% 9.8% 9.0% 8.9% 8.6% 5.5% 1.3% 0.6% -0.7% 1.6% 0.8% -1.9% -4.7% -3.7% -1.8% -1.84%
ROIC 12.1% 14.4% 14.1% 15.5% 14.5% 11.1% 10.3% 9.6% 9.0% 9.3% 6.3% 1.7% 0.5% -1.7% 1.6% -0.1% -5.0% -8.8% -7.1% -4.3% -4.30%
ROCE 13.7% 15.7% 16.5% 19.2% 17.7% 14.6% 14.2% 12.3% 11.6% 11.9% 7.3% 2.1% 0.6% -1.6% 2.3% 0.8% -3.6% -8.4% -6.5% -3.2% -3.24%
Gross Margin 26.5% 25.7% 22.7% 22.1% 23.7% 24.6% 18.9% 12.9% 23.4% 21.8% 2.3% 6.1% 19.4% 16.0% 15.3% -4.1% 3.7% -1.0% 19.5% -42.4% -42.44%
Operating Margin 16.7% 15.2% 11.0% 15.7% 12.6% 10.6% 7.1% 9.6% 12.4% 10.9% -11.4% -6.6% 7.5% 3.5% 1.6% -16.9% -9.6% -16.0% 8.4% -1.0% -1.01%
Net Margin 11.8% 10.8% 7.8% 12.8% 8.9% 7.5% 5.0% 10.3% 8.8% 7.8% -8.1% -4.4% 5.8% 3.1% 1.8% -10.0% -5.7% -10.6% 6.7% -0.8% -0.83%
EBITDA Margin 18.8% 17.5% 13.6% 23.8% 20.2% 39.7% 14.5% 17.0% -0.4% 19.7% 23.1% 3.1% 17.3% 8.3% 6.6% -10.0% 5.5% -10.8% 13.4% 4.1% 4.08%
FCF Margin -3.6% 4.4% -7.4% -3.9% 4.1% -3.1% -3.5% -6.9% -7.3% -3.8% 4.2% 9.6% 8.2% 14.1% 12.6% 15.0% 14.7% 3.5% 0.7% 5.5% 5.54%
OCF Margin 1.3% 9.8% -0.7% 3.7% 13.6% 7.9% 6.0% 0.5% -1.4% 0.5% 7.5% 13.1% 10.9% 15.7% 14.5% 16.0% 16.0% 4.6% 1.5% 6.0% 6.03%
ROE 3Y Avg snapshot only 0.20%
ROE 5Y Avg snapshot only 6.69%
ROA 3Y Avg snapshot only 0.13%
ROIC 3Y Avg snapshot only -0.28%
ROIC Economic snapshot only -2.90%
Cash ROA snapshot only 5.16%
Cash ROIC snapshot only 8.45%
CROIC snapshot only 7.77%
NOPAT Margin snapshot only -3.07%
Pretax Margin snapshot only -2.63%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 19.78%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
P/E Ratio 11.76 12.32 13.28 10.97 10.38 15.48 14.23 11.56 12.37 11.53 26.73 80.08 162.81 -124.15 64.93 133.12 -56.94 -21.65 -25.23 -38.40 -7.082
P/S Ratio 1.07 1.21 1.34 1.20 1.06 1.45 1.21 0.92 0.98 0.92 1.41 1.07 0.92 0.92 0.99 1.10 1.13 1.20 1.10 0.82 0.739
P/B Ratio 1.83 2.12 2.32 2.07 1.77 2.49 2.19 1.61 1.67 1.58 2.39 1.78 1.49 1.47 1.60 1.71 1.68 1.71 1.48 1.11 0.911
P/FCF -29.78 27.64 -18.14 -30.69 25.81 -47.22 -35.08 -13.31 -13.52 -24.35 33.73 11.18 11.16 6.55 7.84 7.35 7.72 34.52 166.95 14.87 14.873
P/OCF 80.51 12.31 — 32.34 7.76 18.38 20.29 194.12 — 182.37 18.75 8.13 8.38 5.86 6.81 6.88 7.10 26.29 75.13 13.67 13.667
EV/EBITDA 8.71 8.66 9.39 7.04 6.04 6.88 6.12 5.24 7.28 9.17 11.12 11.23 7.04 8.17 11.96 13.58 34.49 -90.37 478.08 21.91 21.910
EV/Revenue 1.23 1.31 1.47 1.32 1.16 1.70 1.48 1.17 1.27 1.19 1.64 1.25 1.10 1.03 1.05 0.89 1.13 1.33 1.21 0.80 0.797
EV/EBIT 10.37 10.21 11.09 8.86 8.37 13.40 12.82 11.76 12.79 11.90 26.79 69.12 198.69 -77.76 56.30 130.09 -36.52 -16.03 -18.16 -24.67 -24.671
EV/FCF -34.03 29.94 -19.88 -33.74 28.25 -55.42 -42.78 -16.92 -17.47 -31.54 39.30 13.07 13.35 7.31 8.33 5.98 7.70 38.35 184.93 14.39 14.388
Earnings Yield 8.5% 8.1% 7.5% 9.1% 9.6% 6.5% 7.0% 8.6% 8.1% 8.7% 3.7% 1.2% 0.6% -0.8% 1.5% 0.8% -1.8% -4.6% -4.0% -2.6% -2.60%
FCF Yield -3.4% 3.6% -5.5% -3.3% 3.9% -2.1% -2.9% -7.5% -7.4% -4.1% 3.0% 8.9% 9.0% 15.3% 12.8% 13.6% 12.9% 2.9% 0.6% 6.7% 6.72%
Price/Tangible Book snapshot only 1.146
EV/OCF snapshot only 13.222
Shareholder Yield snapshot only 1.11%
Leverage & Solvency
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Current Ratio 4.02 3.63 4.09 3.44 3.61 3.03 3.04 3.25 3.75 4.32 4.31 3.61 4.14 4.20 4.22 4.02 4.43 3.73 5.08 3.72 3.720
Quick Ratio 4.02 3.63 4.09 3.44 3.61 3.03 3.04 3.25 3.75 4.32 4.31 3.61 4.14 4.20 4.22 4.02 4.43 3.73 5.08 3.72 3.720
Debt/Equity 0.46 0.42 0.38 0.44 0.40 0.58 0.55 0.50 0.54 0.52 0.51 0.49 0.46 0.43 0.41 0.10 0.37 0.51 0.48 0.46 0.457
Net Debt/Equity 0.26 0.18 0.22 0.21 0.17 0.43 0.48 0.44 0.49 0.47 0.39 0.30 0.29 0.17 0.10 -0.32 -0.01 0.19 0.16 -0.04 -0.036
Debt/Assets 0.27 0.25 0.24 0.27 0.26 0.33 0.32 0.30 0.33 0.32 0.32 0.30 0.29 0.28 0.27 0.06 0.26 0.31 0.31 0.29 0.290
Debt/EBITDA 1.90 1.59 1.41 1.35 1.24 1.37 1.25 1.27 1.83 2.31 2.03 2.67 1.82 2.16 2.86 0.93 7.71 -24.47 140.76 9.31 9.308
Net Debt/EBITDA 1.09 0.67 0.82 0.64 0.52 1.02 1.10 1.12 1.64 2.09 1.58 1.63 1.16 0.85 0.72 -3.12 -0.10 -9.02 46.48 -0.74 -0.738
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.69 1.69 1.60 1.59 1.54 1.76 1.73 1.68 1.67 1.62 1.61 1.63 1.60 1.54 1.52 1.50 1.46 1.65 1.54 1.58 1.580
Cash Ratio snapshot only 2.121
Cash to Debt snapshot only 1.079
FCF to Debt snapshot only 0.164
Efficiency & Turnover
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Asset Turnover 1.06 1.08 1.12 1.12 1.12 1.06 1.15 1.13 1.12 1.08 1.05 1.01 0.98 1.00 1.04 0.99 0.95 0.86 0.85 0.86 0.860
Inventory Turnover 36834374.00 — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 3.20 3.02 3.29 3.34 2.98 3.08 2.93 2.82 2.88 2.96 2.80 2.64 2.69 2.82 3.15 3.40 3.26 2.91 2.81 3.62 3.620
Payables Turnover 28.60 21.91 29.51 19.07 26.01 17.15 26.47 19.69 32.38 23.72 27.16 22.12 23.58 36.34 44.71 34.41 22.17 32.83 45.60 30.98 30.982
DSO 114 121 111 109 122 118 124 129 127 123 130 138 136 129 116 107 112 125 130 101 100.8 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 13 17 12 19 14 21 14 19 11 15 13 16 15 10 8 11 16 11 8 12 11.8 days
Cash Conversion Cycle 101 104 98 90 108 97 111 111 115 108 117 122 120 119 108 97 95 114 122 89 89.1 days
Fixed Asset Turnover snapshot only 2.013
Cash Velocity snapshot only 2.737
Capital Intensity snapshot only 1.169
Growth (YoY)
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Revenue 28.4% 25.3% 22.7% 24.4% 13.7% 11.8% 18.1% 14.7% 14.2% 13.5% 0.8% -5.3% -6.1% -9.3% -3.2% -6.5% -12.3% -18.4% -22.1% -16.6% -16.60%
Net Income 32.5% 36.3% 34.1% 49.5% 27.1% 7.1% -0.0% -16.9% -11.3% -3.5% -37.7% -84.1% -93.3% -1.1% -72.1% -42.1% -4.1% -5.1% -3.2% -3.2% -3.17%
EPS 32.4% 36.3% 34.0% 49.6% 27.0% 7.1% -0.0% -16.9% -11.3% -3.5% -37.7% -84.1% -93.3% -1.1% -72.1% -42.1% -4.1% -5.1% -3.2% -3.2% -3.17%
FCF -41.3% 2.5% -2.8% -2.4% 2.3% -1.8% 44.6% -1.0% -3.0% -39.5% 2.2% 2.3% 2.1% 4.4% 1.9% 46.3% 56.8% -79.8% -95.9% -69.1% -69.12%
EBITDA 31.8% 35.2% 33.2% 66.8% 54.9% 83.3% 83.0% 36.2% 3.7% -40.4% -38.5% -52.8% -15.9% -12.1% -42.4% -44.7% -81.5% -1.1% -97.7% -53.9% -53.89%
Op. Income 30.9% 35.5% 33.9% 60.8% 34.1% 10.9% 2.6% -23.7% -18.3% -10.5% -46.7% -83.1% -95.2% -1.1% -76.9% -1.0% -8.3% -4.0% -5.1% -95.6% -95.58%
OCF Growth snapshot only -68.53%
Asset Growth snapshot only 0.94%
Equity Growth snapshot only -3.97%
Debt Growth snapshot only 3.61%
Shares Change snapshot only 0.00%
Dividend Growth snapshot only 0.00%
Growth (CAGR)
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Revenue 3Y 12.3% 14.4% 15.9% 17.1% 16.5% 18.4% 19.6% 18.8% 18.6% 16.7% 13.5% 10.6% 6.8% 4.8% 4.8% 0.5% -2.0% -5.6% -8.7% -9.6% -9.60%
Revenue 5Y 12.0% 12.9% 12.1% 11.8% 10.3% 10.0% 11.5% 12.6% 13.0% 13.7% 13.1% 11.8% 11.1% 11.3% 10.8% 8.2% 6.5% 3.3% 2.0% 1.1% 1.06%
EPS 3Y 7.6% 14.8% 17.2% 19.9% 19.2% 18.8% 22.1% 22.9% 14.3% 12.1% -5.8% -41.8% -57.8% — -44.2% -57.6% — — — — —
EPS 5Y 22.5% 23.4% 20.3% 16.2% 9.6% 6.6% 5.2% 5.8% 7.0% 9.4% 0.0% -25.6% -36.9% — -20.5% -29.8% — — — — —
Net Income 3Y 7.6% 14.8% 17.2% 20.0% 19.2% 18.8% 22.1% 22.9% 14.3% 12.1% -5.8% -41.8% -57.8% — -44.2% -57.6% — — — — —
Net Income 5Y 22.5% 23.4% 20.3% 16.3% 9.6% 6.6% 5.2% 5.8% 7.0% 9.4% 0.0% -25.6% -36.9% — -20.5% -29.8% — — — — —
EBITDA 3Y 1.8% 8.4% 11.8% 21.7% 26.3% 42.8% 50.6% 49.1% 28.4% 13.9% 14.5% 2.4% 10.5% -1.3% -13.5% -29.2% -45.6% — -80.0% -50.6% -50.62%
EBITDA 5Y 14.2% 15.8% 14.7% 14.5% 10.4% 15.1% 15.1% 15.5% 11.1% 6.8% 9.5% 3.0% 11.9% 8.8% 3.9% -2.9% -20.0% — -54.5% -22.8% -22.84%
Gross Profit 3Y 10.4% 10.5% 9.4% 16.7% 18.2% 20.7% 23.9% 6.6% 3.6% 1.5% -7.9% -13.7% -17.9% -23.3% -17.4% -19.0% -29.3% -46.0% -43.5% — —
Gross Profit 5Y 19.2% 19.7% 18.5% 12.8% 8.4% 9.7% 12.0% 3.4% 4.1% 2.8% -3.6% -0.3% -0.8% -2.8% 3.4% -7.1% -16.2% -29.3% -27.5% — —
Op. Income 3Y -1.5% 5.7% 9.5% 17.1% 18.9% 21.0% 25.8% 22.2% 12.8% 10.4% -9.9% -40.8% -62.5% — -49.8% — — — — — —
Op. Income 5Y 15.7% 16.9% 15.1% 12.2% 5.4% 2.5% 0.9% -0.1% 0.9% 3.2% -6.5% -27.0% -41.9% — -24.5% — — — — — —
FCF 3Y — 30.9% — — -7.2% — — — — — 6.7% 52.9% — 54.8% — — 49.9% — — — —
FCF 5Y — 2.3% — — -9.9% — — — — — 20.2% 29.6% 11.4% 48.9% 59.5% — — — -32.1% 10.1% 10.07%
OCF 3Y -32.5% 27.5% — -16.7% 19.1% 18.1% 16.3% -43.1% — 3.2% 6.6% 26.4% 1.2% 22.7% — 63.4% 3.3% -21.4% -43.0% 1.1% 1.11%
OCF 5Y -8.7% 16.9% — -3.1% 10.7% 1.1% 5.7% -40.9% — -33.0% 10.1% 17.3% 7.8% 27.6% 30.1% 40.7% 72.8% 49.1% -29.3% -6.3% -6.31%
Assets 3Y 30.1% 30.4% 27.8% 26.6% 26.2% 32.7% 31.0% 30.8% 12.7% 10.2% 9.1% 7.4% 6.6% 5.0% 5.4% 1.9% 0.1% -1.9% -3.3% -3.4% -3.39%
Assets 5Y 24.6% 24.4% 22.3% 22.4% 22.0% 25.4% 25.6% 22.7% 23.2% 22.6% 20.7% 18.4% 18.2% 17.7% 16.4% 14.9% 3.3% 4.0% 3.3% 2.9% 2.88%
Equity 3Y 15.0% 15.2% 14.9% 15.0% 15.1% 15.1% 15.2% 15.3% 14.7% 14.7% 12.5% 10.1% 8.7% 8.2% 7.3% 3.9% 1.9% 0.4% 0.4% -1.4% -1.36%
Book Value 3Y 15.0% 15.2% 14.9% 14.9% 15.1% 15.0% 15.2% 15.3% 14.7% 14.7% 12.5% 10.1% 8.7% 8.2% 7.3% 3.9% 1.9% 0.4% 0.4% -1.4% -1.36%
Dividend 3Y 5.2% 16.3% 16.3% 16.2% 16.2% 4.3% 4.3% 4.3% 4.3% -7.2% -7.2% -7.2% -7.2% -20.6% -20.6% -20.6% -20.6% 0.0% 0.0% 0.0% 0.00%
Growth Quality
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Revenue Stability 0.86 0.86 0.87 0.83 0.80 0.80 0.82 0.88 0.93 0.97 0.96 0.90 0.89 0.83 0.81 0.58 0.41 0.16 0.07 0.01 0.013
Earnings Stability 0.59 0.61 0.54 0.50 0.59 0.59 0.48 0.47 0.71 0.84 0.19 0.02 0.06 0.11 0.15 0.27 0.48 0.57 0.71 0.75 0.751
Margin Stability 0.84 0.83 0.78 0.91 0.89 0.87 0.82 0.84 0.83 0.81 0.72 0.74 0.73 0.69 0.71 0.68 0.56 0.44 0.48 0.16 0.156
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1
Earnings Persistence 0.87 0.85 0.86 0.80 0.89 0.97 1.00 0.93 0.95 0.99 0.85 0.50 0.50 0.20 0.50 0.83 0.20 0.50 0.20 0.20 0.200
Earnings Smoothness 0.72 0.69 0.71 0.60 0.76 0.93 1.00 0.82 0.88 0.96 0.54 0.00 0.00 — 0.00 0.47 — — — — —
ROE Trend 0.01 0.03 0.03 0.06 0.02 0.00 -0.01 -0.03 -0.03 -0.03 -0.07 -0.14 -0.14 -0.16 -0.10 -0.07 -0.10 -0.14 -0.12 -0.05 -0.047
Gross Margin Trend 0.02 0.03 0.05 -0.04 -0.05 -0.05 -0.07 -0.07 -0.06 -0.07 -0.10 -0.08 -0.09 -0.10 -0.05 -0.04 -0.07 -0.11 -0.10 -0.17 -0.171
FCF Margin Trend -0.06 0.05 -0.11 -0.06 0.08 -0.03 -0.02 -0.07 -0.08 -0.04 0.10 0.15 0.10 0.18 0.12 0.14 0.14 -0.02 -0.08 -0.07 -0.067
Sustainable Growth Rate 14.5% 15.1% 15.5% 17.3% 15.3% 13.8% 13.0% 11.6% 11.2% 12.2% 6.8% -0.2% -1.4% — 1.3% 0.1% — — — — —
Internal Growth Rate 9.2% 9.4% 10.2% 11.6% 10.5% 8.7% 8.5% 7.6% 7.5% 7.8% 4.3% — — — 0.9% 0.1% — — — — —
Cash Flow Quality
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
OCF/Net Income 0.15 1.00 -0.07 0.34 1.34 0.84 0.70 0.06 -0.18 0.06 1.43 9.85 19.43 -21.19 9.54 19.36 -8.02 -0.82 -0.34 -2.81 -2.810
FCF/OCF -2.70 0.45 9.87 -1.05 0.30 -0.39 -0.58 -14.59 5.17 -7.49 0.56 0.73 0.75 0.89 0.87 0.94 0.92 0.76 0.45 0.92 0.919
FCF/Net Income snapshot only -2.582
OCF/EBITDA snapshot only 1.657
CapEx/Revenue 4.9% 5.4% 6.6% 7.6% 9.5% 11.0% 9.4% 7.4% 5.8% 4.3% 3.3% 3.6% 2.7% 1.7% 1.9% 1.0% 1.3% 1.1% 0.8% 0.5% 0.49%
CapEx/Depreciation snapshot only 0.071
Accruals Ratio 0.08 -0.00 0.12 0.08 -0.04 0.02 0.03 0.08 0.10 0.08 -0.02 -0.12 -0.10 -0.16 -0.14 -0.15 -0.17 -0.09 -0.05 -0.07 -0.070
Sloan Accruals snapshot only -0.064
Cash Flow Adequacy snapshot only 4.293
Dividends & Buybacks
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Dividend Yield 1.1% 1.5% 1.3% 1.4% 1.6% 1.3% 1.4% 1.8% 1.7% 1.4% 1.0% 1.3% 1.6% 0.8% 0.7% 0.7% 0.7% 0.7% 0.8% 1.1% 0.00%
Dividend/Share $0.70 $1.10 $1.10 $1.10 $1.10 $1.25 $1.25 $1.25 $1.25 $1.00 $1.00 $1.00 $1.00 $0.50 $0.50 $0.50 $0.50 $0.50 $0.50 $0.50 $0.00
Payout Ratio 13.4% 18.8% 17.9% 15.6% 16.6% 19.9% 20.3% 21.3% 21.2% 16.5% 26.1% 1.1% 2.5% — 46.7% 92.5% — — — — —
FCF Payout Ratio — 42.1% — — 41.2% — — — — — 32.9% 14.9% 17.4% 5.2% 5.6% 5.1% 5.6% 25.6% 1.4% 16.5% 16.53%
Total Payout Ratio 13.4% 18.8% 17.9% 15.6% 16.6% 19.9% 20.3% 21.3% 21.2% 16.5% 26.1% 1.1% 2.5% — 46.7% 92.5% — — — — —
Div. Increase Streak 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number 0.18 0.59 0.58 0.59 0.59 0.15 0.15 0.15 0.15 -0.19 -0.19 -0.19 -0.18 -0.49 -0.49 -0.49 -0.49 0.01 0.01 0.01 0.011
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 1.1% 1.5% 1.3% 1.4% 1.6% 1.3% 1.4% 1.8% 1.7% 1.4% 1.0% 1.3% 1.6% 0.8% 0.7% 0.7% 0.7% 0.7% 0.8% 1.1% 1.11%
DuPont Factors
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Tax Burden (NI/EBT) 0.76 0.76 0.76 0.73 0.74 0.74 0.74 0.80 0.80 0.80 0.86 0.74 0.84 0.62 0.77 1.01 0.64 0.69 0.68 0.81 0.815
Interest Burden (EBT/EBIT) 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.21 0.91 1.06 1.18 1.00 0.96 0.96 0.82 0.815
EBIT Margin 0.12 0.13 0.13 0.15 0.14 0.13 0.12 0.10 0.10 0.10 0.06 0.02 0.01 -0.01 0.02 0.01 -0.03 -0.08 -0.07 -0.03 -0.032
Asset Turnover 1.06 1.08 1.12 1.12 1.12 1.06 1.15 1.13 1.12 1.08 1.05 1.01 0.98 1.00 1.04 0.99 0.95 0.86 0.85 0.86 0.860
Equity Multiplier 1.73 1.75 1.68 1.67 1.61 1.73 1.67 1.64 1.61 1.69 1.67 1.66 1.63 1.58 1.56 1.57 1.53 1.59 1.53 1.54 1.541
Per Share
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
EPS (Diluted TTM) $5.23 $5.86 $6.15 $7.08 $6.64 $6.28 $6.14 $5.88 $5.89 $6.06 $3.83 $0.93 $0.39 $-0.51 $1.07 $0.54 $-1.22 $-3.12 $-2.38 $-1.17 $-1.17
Book Value/Share $33.50 $34.04 $35.11 $37.50 $39.03 $39.05 $40.01 $42.12 $43.67 $44.11 $42.84 $42.05 $43.06 $43.10 $43.41 $42.09 $41.34 $39.48 $40.53 $40.42 $36.23
Tangible Book/Share $32.35 $32.89 $33.96 $36.35 $37.88 $37.90 $38.86 $40.97 $42.52 $42.96 $41.69 $40.90 $41.91 $41.95 $42.26 $40.94 $40.19 $38.33 $39.38 $39.27 $39.27
Revenue/Share $57.28 $59.91 $60.99 $64.51 $65.11 $66.94 $72.02 $73.96 $74.34 $75.99 $72.60 $70.06 $69.80 $68.90 $70.28 $65.51 $61.25 $56.25 $54.78 $54.64 $44.66
FCF/Share $-2.06 $2.62 $-4.50 $-2.53 $2.67 $-2.06 $-2.49 $-5.11 $-5.39 $-2.87 $3.04 $6.69 $5.73 $9.70 $8.87 $9.80 $8.99 $1.96 $0.36 $3.03 $-0.07
OCF/Share $0.76 $5.87 $-0.46 $2.40 $8.88 $5.29 $4.31 $0.35 $-1.04 $0.38 $5.46 $9.20 $7.63 $10.84 $10.20 $10.46 $9.79 $2.57 $0.80 $3.29 $0.39
Cash/Share $6.57 $8.38 $5.62 $8.63 $8.93 $5.86 $2.67 $2.44 $2.46 $2.16 $4.88 $8.14 $7.20 $11.36 $13.25 $17.43 $15.69 $12.82 $13.11 $19.96 $17.90
EBITDA/Share $8.06 $9.04 $9.53 $12.12 $12.48 $16.57 $17.43 $16.50 $12.94 $9.87 $10.72 $7.79 $10.88 $8.68 $6.18 $4.31 $2.01 $-0.83 $0.14 $1.99 $1.99
Debt/Share $15.33 $14.41 $13.46 $16.35 $15.44 $22.72 $21.88 $20.94 $23.74 $22.78 $21.80 $20.80 $19.80 $18.74 $17.67 $4.01 $15.48 $20.30 $19.57 $18.49 $18.49
Net Debt/Share $8.76 $6.03 $7.84 $7.71 $6.52 $16.86 $19.21 $18.49 $21.28 $20.62 $16.92 $12.67 $12.61 $7.37 $4.42 $-13.42 $-0.21 $7.49 $6.46 $-1.47 $-1.47
Academic Models
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.128
Altman Z-Prime snapshot only 6.161
Piotroski F-Score 5 8 6 7 6 3 3 3 4 6 6 5 6 4 6 6 5 3 5 3 3
Beneish M-Score -1.55 -2.44 -1.66 -1.36 -2.75 -2.45 -2.12 -1.42 -1.76 -1.81 1.06 -3.13 -3.02 -3.39 -3.69 -4.85 -1.49 -12.00 -2.88 -3.54 -3.538
Ohlson O-Score snapshot only -6.621
ROIC (Greenblatt) snapshot only -3.35%
Net-Net WC snapshot only $11.56
EVA snapshot only $-4982064.70
Credit
Metric Trend Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Current
Credit Rating snapshot only BBB+
Credit Score 82.90 88.14 82.00 82.64 88.12 81.91 82.70 79.97 78.39 81.24 84.59 86.38 86.14 74.17 88.30 81.12 72.22 69.64 61.76 61.85 61.853
Credit Grade snapshot only 8
Credit Trend snapshot only -19.264
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 56
Sector Credit Rank snapshot only 54

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms